SLC6A3 and Parkinson disease: Here, we provide deep phenotyping data, including a comprehensive assessment of non‐motor symptoms, of 11 PARK‐RAB32 PD patients and one non‐manifesting carrier of the RAB32 p.Ser71Arg variant, including magnetic resonance (MR) imaging and dopamine transporter scan (DaTSCAN) data for a subset, and compare these findings with 72 RAB32‐linked PD patients published to date by applying the standardized MDSGene protocol.11, 12